Skip to main content
. 2011 Jul;85(14):6977–6985. doi: 10.1128/JVI.00179-11

Fig. 2.

Fig. 2.

The number of positive responses (defined as having a magnitude of >50 SFU/million PBMC and >2 times the magnitude of the negative control after subtraction of the value of the negative control in IFN-γ ELISPOT assays) to each HERV peptide among all study subjects.